0 CHECKOUT

Global Drug Delivery Partnering 2010-2016: Deal trends, players and financials

  • ID: 2314812
  • April 2016
  • Region: Global
  • 800 Pages
  • CurrentPartnering
1 of 5

FEATURED COMPANIES

  • 3M
  • Biovail
  • EKR Therapeutics
  • Isis Pharmaceuticals
  • NovaDel Pharma
  • Scynexis
  • MORE

The Global Drug Delivery Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.

This report provides details of the latest Drug Delivery agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Drug Delivery partnering deals.

The report presents financial deal term values for Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Drug Delivery partnering field; both the leading deal values and most active Drug Delivery dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 1,800 online deal READ MORE >

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M
  • Biovail
  • EKR Therapeutics
  • Isis Pharmaceuticals
  • NovaDel Pharma
  • Scynexis
  • MORE

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Drug Delivery dealmaking

2.1. Introduction
2.2. Drug Delivery partnering over the years
2.3. Most active Drug Delivery dealmakers
2.4. Drug Delivery partnering by deal type
2.5. Drug Delivery partnering by therapy area
2.6. Deal terms for Drug Delivery partnering
2.6.1 Drug Delivery partnering headline values
2.6.2 Drug Delivery deal upfront payments7
2.6.3 Drug Delivery deal milestone payments
2.6.4 Drug Delivery royalty rates

Chapter 3 - Leading Drug Delivery deals

3.1. Introduction
3.2. Top Drug Delivery deals by value

Chapter 4 - Most active Drug Delivery dealmakers

4.1. Introduction
4.2. Most active Drug Delivery dealmakers
4.3. Most active Drug Delivery partnering company profiles

Chapter 5 - Drug Delivery contracts dealmaking directory

5.1. Introduction
5.2. Drug Delivery contracts dealmaking directory

Chapter 6 - Drug Delivery dealmaking by technology type

Chapter 7 - Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - Drug Delivery deals by company A-Z

Appendix 2 - Drug Delivery deals by stage of development

Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation

Appendix 3 - Drug Delivery deals by deal type

Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Litigation
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination
Warranty

Appendix 4 - Drug Delivery deals by therapy area

Appendix 5 -Deal type definitions

About

Recent report titles

Table of figures

Figure 1: Drug Delivery partnering since 2010
Figure 2: Active Drug Delivery dealmaking activity- 2010 to 2016
Figure 3: Drug Delivery partnering by deal type since 2010
Figure 4: Drug Delivery partnering by disease type since 2010
Figure 5: Drug Delivery deals with a headline value
Figure 6: Drug Delivery deals with an upfront value
Figure 7: Drug Delivery deals with a milestone value
Figure 8: Drug Delivery deals with a royalty rate value
Figure 9: Top Drug Delivery deals by value since 2010
Figure 10: Most active Drug Delivery dealmakers 2010 to 2016
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events

Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • 3M
  • Biovail
  • EKR Therapeutics
  • Isis Pharmaceuticals
  • NovaDel Pharma
  • Scynexis
  • MORE

Global Drug Delivery Partnering 2010-2015 provides the reader with the following key benefits:

- In-depth understanding of Drug Delivery deal trends since 2010
- Access to headline, upfront, milestone and royalty data
- Analysis of the structure of Drug Delivery agreements with numerous real life case studies
- Detailed access to actual Drug Delivery contracts entered into by leading biopharma companies
- Identify most active Drug Delivery dealmakers since 2010
- Insight into terms included in a Drug Delivery partnering agreement, with real world examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Note: Product cover images may vary from those shown
4 of 5

3M
3M Drug Delivery Systems
AAIPharma Services
Abbott
Accredo Health Group
Acelrx Pharmaceuticals
Acorda Therapeutics
Actavis
Actelion
Actient Pharmaceuticals
Adeona Pharmaceuticals
Adolor
Alchemia
Aldexa Therapeutics
Alexza Pharmaceuticals
Alfacell
Alimera Sciences
Alkermes
Allergan
Allos Therapeutics
Amag Pharmaceuticals
AMAG Pharmaceuticals
Amarillo Biosciences
Amarin
Amicus Therapeutics
Ampio Pharmaceuticals
Amylin Pharmaceuticals
Anesiva
Angiotech Pharmaceuticals
AP Pharma
Apricus Biosciences
Aradigm
Aristos Pharmaceuticals
Arius Pharmaceuticals
Array Biopharma
Astellas
AstraZeneca
Audeo Oncology
Auxilium Pharmaceuticals
AVI Pharma
Azur Pharma
Bausch & Lomb
Baxter International
Bayer
BIND Biosciences
BIND Therapeutics
BioArray Solutions
Biocon
BioCryst Pharmaceuticals
BioDelivery Sciences
Biogen Idec
BiolineRX
Bio-Path
Biopharmex
BioSante Pharmaceuticals
Biovail
BioZone Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Calando Pharmaceuticals
Caleco Pharma
Caleco Pharma Europe
Cambridge Laboratories
Cangene
Caraco Pharmaceuticals
Cardinal Health
Cardium Therapeutics
Cary Pharmaceuticals
Catalent Pharma Solutions
Celgene
Celladon
Cerulean Pharma
Clarus Therapeutics
Columbia Laboratories
CombinatoRx
Control Delivery Systems
Corium International
Cornerstone Therapeutics
Cortex Pharmaceuticals
Crawford Healthcare
Critical Therapeutics
CSL
Cubist
Cumberland Pharmaceuticals
Cutanea Life Sciences
Cyclacel Pharmaceuticals
CyDex
Cypress Bioscience
Daiichi Sankyo
Dainippon Sumitomo
Dalian Wande Electronics
Debiopharm
Dechra Pharmaceuticals
Defense Threat Reduction Agency
Dehaier Medical Systems
Dendreon
Department of Defense
Department of Homeland Security
DepoMed
Dey Pharma
Dipexium Pharmaceuticals
DNA Biomedical Solutions
DoctorDirectory
Dov Pharmaceutical
DPT Laboratories
Drugs for Neglected Diseases Initiative
Duoject Medical Systems
Duramed
Durect
Dyax
Echo Therapeutics
ECR Pharmaceuticals
Egalet
Eisai
EKR Therapeutics
Elan
Eli Lilly
Elite Pharmaceuticals
Emergent BioSolutions
Emisphere
Endo Pharmaceuticals
Entera Bio
Epic Pharmaceuticals
Evonik Industries
Facet Biotechnology
FasTrack Pharmaceuticals
Ferndale Pharmaceuticals
Finorga
Fleet Laboratories
Forest Laboratories
Fovea Pharmaceuticals
Fresenius
Galapagos
Galderma
Genentech
Generex Biotechnology
GenVec
Ghent University
Gilead Sciences
GlaxoSmithKline
Global Health Ventures
Globe Laboratories
GlobeImmune
Graceway Pharmaceuticals
Green Vision
Grifols
Hadasit Medical Research Services and Development
Halo Pharmaceutical
Halozyme Therapeutics
Hangzhou Zhencheng Pharmaceuticals
Helix BioMedix
Horizon Pharma AG
Horizon Pharma Inc
Hospira
Hunan Jiuwang Pharmaceuticals
Idenix Pharmaceuticals
Ikaria
ImaRX
Imprimis Pharmaceuticals
Inalco Biochemicals
Inalco Group
Incyte
Inovio Pharmaceuticals
Insmed Inc
Inspire Pharmaceuticals
Intas Biopharmaceuticals
IntelGenx
Intendis
InterMune
Intrexon
Ipsen
Ironwood Pharmaceuticals
Isis Pharmaceuticals
Jagotec
Janssen Pharmaceuticals
Javelin Pharmaceuticals
Jazz Pharmaceuticals
Jiangsu Yabang Pharmaceuticals
Johnson & Johnson
JPI Commercial
King Pharmaceuticals
Krele Pharmaceuticals
Kunwha Pharmaceuticals
KV Pharmaceutical
Kyowa Hakko Kirin
Kythera Biopharmaceuticals
LFB Group
Ligand Pharmaceuticals
Lipocine
Lonza
Los Angeles Biomedical Research Institute
Lundbeck
Lupin Pharmaceuticals
Mallinckrodt Pharmaceuticals
MAP Pharmaceuticals
Marina Biotech
McCoy Enterprises
McKesson
McNeil PPC
MD Anderson Cancer Center
MDRNA
Meda
Medgenics
MediciNova
Medicis Pharma
Medpace
Meiji Seika
Melinta Therapeutics
Memorial Sloan Kettering Cancer Center
Menarini
Merck & Co
Merck KGaA
Merial
Merrimack Pharmaceuticals
Mglas
Microbix Biosystems
MiddleBrook Pharmaceutical
Mikah Pharma
Millennium
Mirna Therapeutics
Mist Acquisition
Monsanto
Morphosys
Mundipharma
Mylan
Mylan Laboratories
Nastech Pharmaceutical
Nektar Therapeutics
NeurogesX
Neuromed
Neuronex
Nitec Pharma
Norgine
NovaDel Pharma
Novartis
Novasep
Novo Nordisk
Novozymes Biopharma
NPS Pharmaceuticals
NuGlow Cosmaceuticals
NuPathe
Nycomed
Oculus Innovative Sciences
Omthera Pharmaceuticals
OncoSec Medical
Onyx Pharmaceuticals
Oradisc
Oramed Pharmaceuticals
Orexigen Therapeutics
Ortho-McNeil-Janssen Pharmaceuticals
Oso Bio Pharmaceuticals
Otsuka
Pacira Pharmaceuticals
Par Pharmaceutical
Patheon
PDL BioPharma
Pfizer
PharmaEngine
Pipex Pharmaceuticals
Planned Systems International (PSI)
Pozen
Prasco Laboratories
Prestige Brands
Procter & Gamble
Professional Compounding Centers of America
ProNAi Therapeutics
PSivida
Purdue
Purdue Pharma
QLT
Questcor Pharmaceuticals
Quintiles
Radius Health
Ranbaxy Laboratories
Receptos
Rechon Life Sciences
RedHill Biopharma
Regeneron Pharmaceuticals
Revance Therapeutics
Rigel Pharmaceuticals
Roche
RRD International
S2 Therapeutics
Sagent Pharmaceuticals
Salix Pharmaceuticals
Sangamo BioSciences
Sankyo Pharmaceutical
Sanofi
Sanofi-Aventis
Santarus
SciClone Pharmaceuticals
Scolr Pharma
Scynexis
Seattle Genetics
Serenity Pharmaceuticals
Servier
Shaanxi Jiali Pharmaceuticals
Shandong Yaoshan Pharmaceuticals
Shionogi
Shire
Sigma-Aldrich
SK Biopharmaceuticals
SkyePharma
SLA Pharma
Smiths Medical
Solvay
Southern Research Institute
Sovereign Pharmaceuticals
Spectrum Pharmaceuticals
Spring Creek Capital
SRI International
Stada
Strakan
Strativa Pharmaceuticals
Sun Pharmaceutical
Supernus Pharmaceuticals
SurModics
Swedish Orphan Biovitrum
Symphony Allegro
Takeda
Tandem Diabetes Care
Tarsa Therapeutics
Teikoku Pharma USA
Teikoku Seiyaku
Teva
The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center
The Medicines Company
The Regents of the University of California
Therabel
Transcept Pharmaceuticals
Transdel Pharmaceuticals
Tranzyme Pharma
TTY Biopharm
UCB
Ultragenyx Pharmaceuticals
Uluru
Unigene Laboratories
United Therapeutics
Valeant
Vanda Pharmaceuticals
Ventrus Biosciences
VeroScience
Vertex Pharmaceuticals
VetCure
Viropharma
WA 32609
Warner Chilcott
Washington Research Foundation
Watson Laboratories
Watson Pharmaceuticals
Xi’an Zaolutang Kushidai Pharmaceuticals
XTL Biopharmaceuticals
Yamasa
Zogenix
ZymoGenetics

Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be shipped to you in CD ROM format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be shipped to you in CD ROM format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be shipped to you in CD ROM format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

  • Quick Help: A copy of the report will be emailed to you and a copy will be shipped to you in CD ROM format. The Electronic copy is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Bayer AG
  • LEO Laboratories Ltd.
  • Grünenthal GmbH
  • Medtronic, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pall Corporation